Asset Details
Do you wish to reserve the book?
The Convergence of Polymer Science and Predictive Modeling for Noninvasive Glucose Monitoring
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Convergence of Polymer Science and Predictive Modeling for Noninvasive Glucose Monitoring
Do you wish to request the book?
The Convergence of Polymer Science and Predictive Modeling for Noninvasive Glucose Monitoring
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Convergence of Polymer Science and Predictive Modeling for Noninvasive Glucose Monitoring
2025
Overview
The global effort to manage diabetes effectively is driving continuous innovation in glucose monitoring devices. While current systems have improved patient care, persistent challenges with sensor stability and invasiveness highlight the need for advanced, patient-friendly technologies. A particularly promising frontier is emerging from the convergence of advanced polymer science and artificial intelligence (AI), opening new pathways for noninvasive biosensing. This feature review provides a comprehensive overview of polymer-based “hardware”, such as molecularly imprinted polymers (MIPs), conductive polymer hydrogels (CPHs), and functional coatings, which offer robust and biocompatible alternatives to traditional enzyme-based sensors. Concurrently, we examine (AI) “software”, including machine learning and predictive modeling, which enable reliable interpretation of complex biosignals for real-time glucose monitoring. Furthermore, this review highlights critical challenges in scalability, long-term in vivo stability, regulatory approval, and clinical adoption, while discussing strategies for successful translation into pharmaceutical technology and medical devices. By mapping the current landscape and future directions, this review aims to guide research toward the next generation of intelligent, patient-centric, noninvasive glucose monitoring platforms.
Publisher
MDPI AG
